LABORATORIO FARMAC.ERFO (RK7) — Working Capital to Net Assets Ratio
LABORATORIO FARMAC.ERFO (RK7) has a Working Capital to Net Assets ratio of 20.1% as of June 2024. Working capital of €1.52 Million (current assets of €3.99 Million minus current liabilities of €2.48 Million) is measured against net assets of €7.54 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See LABORATORIO FARMAC.ERFO financial flexibility index to measure the company's free cash flow as a share of total liabilities.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
LABORATORIO FARMAC.ERFO Working Capital to Net Assets (2021–2021)
This chart shows how LABORATORIO FARMAC.ERFO's Working Capital to Net Assets ratio has evolved across 1 annual periods from 2021 to 2021. As of June 2024, the ratio stands at 20.1%, reflecting working capital of €1.52 Million against net assets of €7.54 Million EUR. See defensive interval ratio of LABORATORIO FARMAC.ERFO to measure how many days the company can operate on defensive assets alone.
Annual Working Capital to Net Assets for LABORATORIO FARMAC.ERFO (2021–2021)
The table below presents the year-by-year Working Capital to Net Assets ratio for LABORATORIO FARMAC.ERFO from 2021 to 2021, covering 1 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see RK7 company net worth.
| Year | WC/NA Ratio | Working Capital (EUR) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2021 | 5.5% | €258.00K | €4.73 Million | €1.57 Million | €1.31 Million | — |